insilico longevity model
6 Errors Bleeding Longevity Science Budgets
Longevity research loses money mainly because teams chase false leads, validate genes too slowly, design inefficient trials, overlook AI potential, miss early senescence cues, and fail to build proactive partnerships. In 2026 the Insilico-Human Longevity collaboration accessed over 20 million multi-omics samples, a scale few initiatives have matched. Medical Disclaimer: